Press release - 22/03/2011 Bringing artifical vision clinical trials to US Retina Implant AG Partners with Wills Eye Institute to Bring Artificial Vision Clinical Trials to the United States. Wills Eye to be the Primary Investigation Site to Offer the Subretinal Approach to Retinitis Pigmentosa Patients.https://www.gesundheitsindustrie-bw.de/en/article/press-release/bringing-artifical-vision-clinical-trials-to-us
Press release - 21/03/2011 Polymer brushes with mini proteins protect implants Patients who have had surgical implants are at risk of developing serious complications due to bacterial infections. This affects around two to six per cent of patients with implants. Scientists from the KIT Institute of Functional Interfaces (IFG) have now succeeded in developing a protective layer that prevents bacteria from adhering to implants and creating dangerous biofilms that can lead to serious infections. The protective layer has proven…https://www.gesundheitsindustrie-bw.de/en/article/press-release/polymer-brushes-with-mini-proteins-protect-implants
Article - 21/03/2011 Immunotherapy: the rocky road to clinical application Hans-Georg Rammensee has one major goal: he wants to contribute to the successful application of immunotherapy in clinical settings and is convinced that this will only be possible once individualised immunotherapies are used. Individualised immunotherapy refers to the induction of a specific immune response against specific tumour-associated antigens. Rammensee has made major progress in this area and is now focused on overcoming the obstacles…https://www.gesundheitsindustrie-bw.de/en/article/news/immunotherapy-the-rocky-road-to-clinical-application
Press release - 21/03/2011 Crop production - plate or tank? As part of the “University of Hohenheim – strength through communication” thematic year 2011, Dr. Detlef Virchow, Executive Manager of the Food Security Center at the University of Hohenheim, talked to us about the medium-term risks of E10 biofuel in relation to global food safety.https://www.gesundheitsindustrie-bw.de/en/article/press-release/crop-production-plate-or-tank
Article - 21/03/2011 C.S.P. – linking cultivation and application A growing number of industrial companies would like to use renewable raw materials for production, out of ecological, economic or technical interest. However, it is not always easy for many of the companies to get into contact with farmers and secure the supply of crops in the quantity and quality they require. Dresden-based C.S.P. Consulting und Service für Pflanzliche Rohstoffe GmbH is now able to use its know-how and that of its partners to…https://www.gesundheitsindustrie-bw.de/en/article/news/c-s-p-linking-cultivation-and-application
Article - 21/03/2011 Andrea Hartwig – trace elements, toxic metals and the thin line in between For more than 25 years Prof. Dr. Andrea Hartwig has been investigating the quantities of metal compounds that have a beneficial or toxic effect on human health. As a basic researcher the new chair of the Department of Food Chemistry and Toxicology at the Karlsruhe Institute of Technology KIT has managed to clarify many mechanisms of action of toxic metals including on the molecular level.https://www.gesundheitsindustrie-bw.de/en/article/news/andrea-hartwig-trace-elements-toxic-metals-and-the-thin-line-in-between
Article - 21/03/2011 Fluoron – a company that is well underway Fluoron is a company that takes close contact with customers very seriously. This is why Christian Lingenfelder and his team frequently pack their suitcases to travel from place to place visiting Russian or Chinese operating theatres. Thousands of kilometres from the company’s production site in Ulm, the Fluoron team exchanges information with the retina surgeons for whom the company develops and produces highly pure biomaterials for use in…https://www.gesundheitsindustrie-bw.de/en/article/news/fluoron-a-company-that-is-well-underway
Article - 20/03/2011 Hannah Monyer: we exist as long as somebody remembers us Prof. Dr. Hannah Monyer, neurobiologist from Heidelberg and Leibniz prizewinner, has spent her entire professional career searching for answers to questions as to how human memory functions. Her investigations focus on the role of the hippocampal interneurons that coordinate the activities of nerve cells involved in spatial short- and long-term memory.https://www.gesundheitsindustrie-bw.de/en/article/news/hannah-monyer-we-exist-as-long-as-somebody-remembers-us
Article - 20/03/2011 Non-pathogenic bacteria for the treatment and prevention of allergies Researchers and physicians from the Department of Dermatology at Tübingen University Hospital are investigating huge numbers of non-pathogenic bacteria with the aim of shedding light on their potential for the prevention and treatment of allergies. The mode of action of highly promising candidates is being investigated in further detail. https://www.gesundheitsindustrie-bw.de/en/article/news/non-pathogenic-bacteria-for-the-treatment-and-prevention-of-allergies
Press release - 19/03/2011 Detailed insights into how HI viruses leave their host cells Highly developed microscope technology makes it possible: researchers led by Dr. Barbara Müller of the Department of Infectiology at Heidelberg University and by Professor Don C. Lamb from the University of Munich, have for the first time ever been able to demonstrate in detail how specific proteins of human immune cells interact with HIV components to enable them to leave the infected cells.https://www.gesundheitsindustrie-bw.de/en/article/press-release/detailed-insights-into-how-hi-viruses-leave-their-host-cells
Article - 18/03/2011 Allergen research – present and future An allergy is a hypersensitivity disorder of the immune system. It is an exaggerated immune reaction to external stimuli such as pollen and is associated with symptoms that range in degree from uncomfortable (hay fever, asthma) to life-threatening (anaphylactic shock). Dr. Thomas Bethke, Medical Director of Nycomed Germany, explains in the following interview how a drug manufacturer approaches the research and development of anti-allergy…https://www.gesundheitsindustrie-bw.de/en/article/news/allergen-research-present-and-future
Article - 14/03/2011 Mast cells as the central and pivotal points of allergy processes Mast cells of the human immune system play a key role in allergic and inflammatory reactions. Activated mast cells release a number of substances that mediate an immune response. The process by which such mediators are released is still largely unknown. Scientists from the University of Hohenheim are focusing on finding out how allergic reactions are induced by mast cells.https://www.gesundheitsindustrie-bw.de/en/article/news/mast-cells-as-the-central-and-pivotal-points-of-allergy-processes
Article - 14/03/2011 Subitec GmbH – binding carbon dioxide, generating energy Algae have become the beacons of hope in terms of energy generation and carbon dioxide fixation. Stuttgart–based Subitec GmbH has developed a unique reactor system to improve the cultivation of algae. The establishment of further pilot plants gives the company access to the constantly growing energy market.https://www.gesundheitsindustrie-bw.de/en/article/news/subitec-gmbh-binding-carbon-dioxide-generating-energy
Article - 14/03/2011 Synthesising proteins from non-natural building blocks? Dr. Birgit Wiltschi from the University of Freiburg has been awarded funding from the Baden-Württemberg Ministry of Science Research and the Arts under the Biotechnology and Medical Technology Idea Competition for a highly ambitious project she wants to learn how proteins can be modified using non-natural building blocks that will enable the engineered proteins to specifically target receptors on cancer cells amongst other things.https://www.gesundheitsindustrie-bw.de/en/article/news/synthesising-proteins-from-non-natural-building-blocks
Press release - 13/03/2011 Vascular stent that dissolves on its own The first ever implant in Germany of a bioresorbable, drug-coated stent in a cardiac patient has been carried out by physicians from the University of Heidelberg. In contrast to traditional metal stents, which remain permanently in the patients’ body, the innovative implant dissolves around two years after the procedure is carried out.https://www.gesundheitsindustrie-bw.de/en/article/press-release/vascular-stent-that-dissolves-on-its-own
Press release - 10/03/2011 Novel High-Resolution Methods in Fluorescence Microscopy Heidelberg scientists have developed a new method by which the physical limits in high-resolution light microscopy can be overcome with the aid of chemical reactions. The scientists replaced light-dependent processes by chemical reactions for light-independent switching of fluorescent probes to mark cellular structures for high-resolution optical microscopy. This method opens up new application vistas for fluorescence microscopy.https://www.gesundheitsindustrie-bw.de/en/article/press-release/novel-high-resolution-methods-in-fluorescence-microscopy
Press release - 10/03/2011 European Commission and EMBL renew cooperation In a Memorandum of Understanding signed on march 4th, the European Commission (EC) and the European Molecular Biology Laboratory (EMBL) formalise their desire to maintain and further develop their cooperation.https://www.gesundheitsindustrie-bw.de/en/article/press-release/european-commission-and-embl-renew-cooperation
Press release - 09/03/2011 DKFZ and IBM have signed a collaboration agreement on cancer genome analysis The International Cancer Genome Project analyzes the complete genomes of thousands of cancer patients. This generates enormous amounts of data. To find those gene segments which are pivotal for cancer development and treatment, intelligent IT systems are needed. The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) in Heidelberg and IBM have signed a strategic partnering agreement at CeBIT 2011. The aim of the agreement is to…https://www.gesundheitsindustrie-bw.de/en/article/press-release/dkfz-and-ibm-have-signed-a-collaboration-agreement-on-cancer-genome-analysis
Article - 07/03/2011 Thomas Brunner: steroid synthesis in the intestine A research team led by Prof. Dr. Thomas Brunner at the University of Konstanz has found out that intestinal epithelial cells are able to synthesise anti-inflammatory steroids glucocorticoids following immunological stress which makes a considerable contribution to the maintenance of local immune homoeostasis. Brunner plans to use his findings to develop a therapeutic approach for the treatment of inflammatory bowel diseases.https://www.gesundheitsindustrie-bw.de/en/article/news/thomas-brunner-steroid-synthesis-in-the-intestine
Press release - 07/03/2011 Review: MicroMountains Innovation Forum 2011: Networking - Motor for Innovation The third MicroMountains Innovation Forum, held in Villingen-Schwenningen on 2nd February 2011, focused exclusively on microtechnologies. In cooperation with the local Chamber of Commerce and Industry, the MicroMountains network provided around 160 participants with insights into the application of microtechnologies in the fields of medical, measurement and automotive technologies as well as giving them the opportunity to exchange experiences. https://www.gesundheitsindustrie-bw.de/en/article/press-release/review-micromountains-innovation-forum-2011-networking-motor-for-innovation
Article - 07/03/2011 Farming lifestyle: microbial diversity keeps allergies away Children who grow up on farms have a lower prevalence of allergies and asthma than other children in the same geographical region who do not grow up in such environments. A study by a European group of researchers published in the renowned New England Journal of Medicine adds to evidence supporting the hygiene hypothesis.https://www.gesundheitsindustrie-bw.de/en/article/news/farming-lifestyle-microbial-diversity-keeps-allergies-away
Article - 06/03/2011 Heidelberg Translational Lung Research Centre University and non-university research institutions in Heidelberg that carry out research into lung diseases have established an expert network – the Heidelberg Translational Lung Research Centre – which is part of the new BMBF-funded German Centre for Lung Research. In Heidelberg, research focuses on the development and treatment of cystic fibrosis, chronic obstructive pulmonary diseases and lung cancer. https://www.gesundheitsindustrie-bw.de/en/article/news/heidelberg-translational-lung-research-centre
Press release - 05/03/2011 Research prize for the gene therapy of rare diseases The Eva Luise and Horst Köhler Foundation for People with Rare Diseases has awarded the 2011 Eva Luise Köhler Research Prize, which includes prize money of 50,000 euros, to an interdisciplinary team of researchers: Professor Dr. Christoph Klein, Department of Paediatric Haematology and Oncology at the Hannover Medical School (MHH), Professor Dr. Christopher Baum, Department of Experimental Haematology (MHH), Professor Dr. Christoph von Kalle,…https://www.gesundheitsindustrie-bw.de/en/article/press-release/research-prize-for-the-gene-therapy-of-rare-diseases
Press release - 02/03/2011 immatics appoints Dr. Harald Stock to its Board immatics biotechnologies GmbH, a late-stage biopharmaceutical company developing therapeutic vaccines that are active against cancer, today announced the appointment of Dr. Harald F. Stock to the board of directors, effective February 2011.https://www.gesundheitsindustrie-bw.de/en/article/press-release/immatics-appoints-dr-harald-stock-to-its-board
Dossier - 28/02/2011 Allergies – a major human plague According to the Federal Health Monitoring Information System a persons life expectancy is reduced by around one per cent due to allergies and their effects. Knowledge about the molecular mechanisms that lead to disorders in the interplay of the immune system and the environment is a prerequisite for developing new therapies for the causal treatment of allergies.https://www.gesundheitsindustrie-bw.de/en/article/dossier/allergies-a-major-human-plague